Details for New Drug Application (NDA): 203182
✉ Email this page to a colleague
The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
Summary for 203182
Tradename: | CISATRACURIUM BESYLATE PRESERVATIVE FREE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | cisatracurium besylate |
Patents: | 0 |
Pharmacology for NDA: 203182
Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Suppliers and Packaging for NDA: 203182
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 203182 | ANDA | Fresenius Kabi USA, LLC | 63323-416 | 63323-416-05 | 10 VIAL in 1 CARTON (63323-416-05) / 5 mL in 1 VIAL (63323-416-01) |
CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 203182 | ANDA | Fresenius Kabi USA, LLC | 63323-418 | 63323-418-20 | 10 VIAL in 1 CARTON (63323-418-20) / 20 mL in 1 VIAL (63323-418-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Feb 26, 2015 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
Approval Date: | Feb 26, 2015 | TE: | AP | RLD: | No |
Complete Access Available with Subscription